http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013088141-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df0fef4a47abbd46e0bcca04bd71f9a3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-595 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa4cb68be3c28f966e2b60114f512687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27fe38deb8d0d8bcd25abe886701c718 |
| publicationDate | 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013088141-A1 |
| titleOfInvention | Polypeptide comprising the sequence egpwleeeeeayg linked to an immunogenic carrier |
| abstract | The present invention provides a compound comprising a polypeptide conjugated to an immunogenic carrier, the polypeptide comprising the sequence EGPWLEEEEEAYG (SEQ ID NO: 1) and having fewer than 17 amino acid residues, for use in medicine. Further, the invention provides a compound comprising a polypeptide conjugated to an immunogenic carrier, the polypeptide comprising the sequence EGPWLEEEEEAYG (SEQ ID NO: 1) and having fewer than 17 amino acid residues, wherein the immunogenic carrier is diphtheria toxoid, tetanus toxoid, keyhole limpet haemocyanin, Purified protein derivative (PPD), Albumin, and/or viral proteins. The polypeptide may be conjugated to the immunogenic carrier via a cysteine residue. Pharmaceutical compositions and kits of parts are also provided. In particular, the use of the compounds in medicine and in the treatment of cancer is provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111050789-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583576-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3624841-A4 |
| priorityDate | 2011-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 308.